Targeting cell pathway may prevent relapse of leukaemia
Friday, March 26, 2010 - 09:00
in Health & Medicine
About 40 percent of children and up to 70 percent of adults in remission from acute myelogenous leukaemia (AML) will have a relapse. In recent years, doctors have come to believe that this is due to leukaemia stem cells, endlessly replicating cancer cells that generate the immature blood cells characteristic of leukaemia and are resistant to typical cancer treatments. Now, researchers at Children's Hospital Boston have found a possible way to kill off these cells, and prevent them from initiating a relapse...